ERMA Systems, an AI-powered SaaS company revolutionizing Promotional and Medical Review Committee (PRC/MRC) processes in the life sciences sector, announced on August 26, 2025, the appointment of Israel Aker, PharmD, RPh, to its Advisory Board. A seasoned Medical Affairs expert from Thermo Fisher Scientific’s PPD clinical research business, Dr. Aker will enhance ERMA’s platform to meet the evolving needs of medical reviewers.
Dr. Aker, currently leading Medical Writing & Promotional Review at Thermo Fisher’s PPD, brings extensive experience in translating complex scientific data into actionable strategies across clinical, regulatory, and commercial teams. His role at ERMA will focus on enhancing the medical review capabilities of ERMA Evaluate™, an AI-powered platform that streamlines compliance and content review for life sciences companies. “His depth of experience in Medical Affairs… will be instrumental,” said Julia Gardner, CEO of ERMA Systems.
ERMA Evaluate™, hosted on AWS, leverages Amazon Textract and Comprehend Medical to process millions of pages of clinical and promotional content, reducing review cycles by up to 50%. The platform supports major clients like Merck, Novartis, and Amgen, addressing inefficiencies in Medical, Legal, and Regulatory (MLR) workflows. “ERMA’s vision aligns perfectly with where the industry is headed—faster, smarter, and more collaborative content review processes,” said Dr. Aker.
The life sciences MLR market, valued at $1.2B in 2024, is growing at a 10% CAGR, driven by increasing regulatory scrutiny and AI adoption, per a 2025 Frost & Sullivan report. ERMA’s platform competes with Veeva Systems but stands out for its AI-driven automation and AWS integration. Dr. Aker’s expertise, highlighted on his LinkedIn profile, aligns with ERMA’s mission to transform PRC/MRC processes for biopharma companies.
Dr. Aker’s appointment, alongside recent additions like Christine Hendrick, reflects ERMA’s commitment to embedding industry expertise into its platform. With Thermo Fisher’s PPD managing $10B+ in clinical research revenue, Aker’s insights will strengthen ERMA’s ability to serve Medical Affairs teams, ensuring compliance and patient impact in a rapidly evolving sector.
ERMA Systems’ appointment of Israel Aker positions it to lead innovation in life sciences MLR processes, leveraging his expertise to enhance AI-driven compliance and strategic content review.
ERMA Systems is an AI-powered SaaS company revolutionizing how Life Sciences organizations manage their Promotional and Medical Review Committee (PRC/MRC) processes. Its flagship platform, ERMA Evaluate™, streamlines internal review workflows—empowering regulatory, medical, and commercial teams to bring compliant materials to market with greater speed, efficiency, and clarity. ERMA Systems is a 100% AWS-hosted SaaS solution that leverages a robust stack of cloud services to power its advanced, AI-enabled MLR workflow. Using Amazon Textract and Amazon Comprehend Medical, ERMA converts millions of pages of prescribing information, promotional content, and clinical trial documentation into structured, actionable data. With Amazon SageMaker powering model training, experimentation, and deployment, ERMA delivers a scalable, low-latency solution that shortens review cycles, enhances compliance accuracy, and adapts in real-time to customer needs.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.